TRIO Pharmaceuticals, Inc.
PrivateLast Round
Pre Seed
Dec 3, 2024
Total Funding Raised
$5.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TRIO Pharmaceuticals, Inc. is a cancer immunotherapeutics company developing a proprietary platform of dual-action tumor immunity-enhancing drugs aimed at treating cancers by targeting specific antigens on cancer cells and immunosuppressor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TRIO Pharmaceuticals, Inc. Comparables
Compare TRIO Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sidewinder Therapeutics | 83% | |
| Biomunex Pharmaceuticals | 83% | |
| EvolveImmune Therapeutics | 81% | |
TRIO Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Dec 3, 2024 | ||||
| Seed | Mar 1, 2023 | ||||
| Grant | Sep 1, 2022 |
TRIO Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Newsight Tech Angels | Seed |
| SeedFolio | Seed |
| TCA Venture Group | Seed |
| Life Science Angels | Seed, Pre Seed |
| Purdue Strategic Ventures | Seed |
| Friedman BioVentures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 117% MoM.
- Dec 3, 2024
$3.1M raised from Life Science Angels and MMRF.
TRIO Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TRIO Pharmaceuticals, Inc.'s valuation, stock price, and market status.